tiprankstipranks
Trending News
More News >

New Portfolio - New Portfolio

Aivo A

New Portfolio
Individual Investor
Ranked #163,137 out of 808,344 TipRanks' Investors
Success Rate
61%
31 out of 51
profitable transactions
Average Return
29.97%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 21.13%
6-Month Return▲ 27.92%
12-Month Return▲ 21.17%
YTD Return▲ 35.75%
Total Return▲ 62.67%

Best Trade

Opened at
Closed at
Gain▲ 809.68%

Bio

Performance

17.78%0-17.78%
▲ 5.10%
▼ 2.41%
▼ 0.08%
Dec 2024
▲ 6.03%
▲ 2.69%
▲ 1.50%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 8.77%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 4.55%
Mar 2025
▲ 1.84%
▼ 0.87%
▲ 4.63%
Apr 2025
▲ 12.20%
▲ 6.28%
▲ 12.19%
May 2025
▲ 6.24%
▲ 5.14%
▲ 11.10%
Jun 2025
▲ 13.92%
▲ 0.69%
▲ 17.78%
Jul 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 5.10%▼ 2.41%▼ 0.08%
▲ 6.03%▲ 2.69%▲ 1.50%
▼ 12.86%▼ 1.27%▼ 8.77%
▼ 1.80%▼ 5.57%▼ 4.55%
▲ 1.84%▼ 0.87%▲ 4.63%
▲ 12.20%▲ 6.28%▲ 12.19%
▲ 6.24%▲ 5.14%▲ 11.10%
▲ 13.92%▲ 0.69%▲ 17.78%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Altimmune
5.14%
▲ 62.27%
4
Buy
Jun 26, 2025
Aeva Technologies
▲ 158.02%
2
Close
May 12, 2025
Rheinmetall
18.75%
▲ 47.69%
1
Open
Apr 07, 2025
Xeris Pharmaceuticals
4.19%
▲ 48.12%
2
Buy
Mar 11, 2025
Chimerix
▲ 809.68%
2
Close
Mar 05, 2025
Rigetti Computing
4.47%
▲ 55.50%
1
Open
Mar 05, 2025
General Dynamics
▲ 23.36%
2
Close
Feb 04, 2025
Black Diamond Therapeutics
4.15%
▲ 19.43%
1
Open
Jan 28, 2025
Outset Medical
3.07%
▲ 9.55%
1
Open
Jan 07, 2025
Tenaya Therapeutics
1.21%
▼ 77.37%
2
Buy
Dec 13, 2024
Zura Bio
1.37%
▼ 51.85%
1
Open
Dec 03, 2024
Cleanspark
5.36%
▲ 8.62%
2
Buy
Sep 03, 2024
uniQure
▲ 38.63%
2
Close
Jul 10, 2024
Oatly Group
▼ 2.33%
2
Close
May 09, 2024
Olema Pharmaceuticals
1.01%
▼ 53.35%
1
Open
May 09, 2024
EOG Resources
▲ 18.37%
2
Close
Apr 09, 2024
Lineage Therap
1.95%
▼ 28.57%
1
Open
Apr 09, 2024
Genco Shipping
▲ 13.01%
4
Close
Mar 01, 2024
Ellington Financial
3.48%
▲ 37.41%
1
Open
Mar 01, 2024
Enovix
4.5%
▲ 54.65%
1
Open
Feb 28, 2024